Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Neurosurg. 2017 Apr 21;128(3):701–709. doi: 10.3171/2016.10.JNS16877

Figure 4.

Figure 4

UCH1, UCH2, UM-Chor1 and fibroblasts from a head and neck patient were analyzed for increased ALDH1 activity by the Aldefluor assay. When compared with a DEAB-inhibited control, UCH1, UCH2, UM-Chor1 registered ALDHhigh populations of .48%, .37%, and .17%, respectively. In contrasts, the fibroblasts measured an ALDHhigh population of 6.83%.